Drug Type Cell therapy |
Synonyms Vavelta, ICX-RHY-013 |
Target |
Mechanism Collagen modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epidermolysis Bullosa | Phase 2 | GB | 12 Jan 2011 | |
Cicatrix | Phase 2 | US | - |